Post by Silence Therapeutics plc

At EHA, we are presenting follow-up and quality-of-life data from our Phase 1 SANRECO study evaluating our siRNA therapy in development for patients living with polycythemia vera (PV). Read more: https://bit.ly/4v7zjvI #SilenceIsGOLDen #EHA2026